NDC 80425-0033

Neurontin

Gabapentin 300mg

Neurontin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Gabapentin.

Product ID80425-0033_b28aaa25-73a9-ff1d-e053-2a95a90a0426
NDC80425-0033
Product TypeHuman Prescription Drug
Proprietary NameNeurontin
Generic NameGabapentin 300mg
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2011-01-29
Marketing CategoryANDA / ANDA
Application NumberANDA090858
Labeler NameAdvanced Rx Pharmacy of Tennessee, LLC
Substance NameGABAPENTIN
Active Ingredient Strength300 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 80425-0033-3

90 CAPSULE in 1 BOTTLE (80425-0033-3)
Marketing Start Date2011-01-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Neurontin" or generic name "Gabapentin 300mg"

NDCBrand NameGeneric Name
0071-0401Neurontingabapentin
0071-0513Neurontingabapentin
0071-0803Neurontingabapentin
0071-0805Neurontingabapentin
0071-0806Neurontingabapentin
0071-2012Neurontingabapentin
70518-1382Neurontingabapentin
70518-1405Neurontingabapentin
80425-0033NeurontinGabapentin 300mg
80425-0034NeurontinGabapentin 300mg
80425-0035NeurontinGabapentin 800mg
80425-0082NeurontinNeurontin
80425-0079NeurontinNeurontin
80425-0036NeurontinNeurontin
80425-0097NeurontinNeurontin

Trademark Results [Neurontin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NEURONTIN
NEURONTIN
78157864 2902252 Dead/Cancelled
WARNER-LAMBERT COMPANY LLC
2002-08-26
NEURONTIN
NEURONTIN
78157862 2931600 Dead/Cancelled
Warner-Lambert Company LLC
2002-08-26
NEURONTIN
NEURONTIN
78157858 2902251 Dead/Cancelled
WARNER-LAMBERT COMPANY LLC
2002-08-26
NEURONTIN
NEURONTIN
73550915 1382989 Live/Registered
WARNER-LAMBERT COMPANY
1985-07-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.